Altered Metabolism in Idiopathic Pulmonary Fibrosis

Area of Science:

• Pulmonary Medicine
• Metabolomics
• Cellular Biology

Background:

• Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with high mortality and limited treatment options.
• IPF involves complex etiology, cellular dysfunction, oxidative stress, and impaired surfactant production.
• Distinct metabolic disturbances are increasingly recognized in IPF pathogenesis.

Purpose of the Study:

• To review mechanisms of IPF development linked to cell-specific metabolic alterations.
• To compare in vivo and in vitro IPF models regarding metabolic analyses.
• To discuss metabolomic biomarkers and therapeutic targeting strategies for IPF.

Main Methods:

• Literature review focusing on IPF mechanisms and metabolic alterations.
• Comparative analysis of various IPF models (in vivo, in vitro) and patient data.
• Identification and discussion of metabolically-associated biomarkers.

Main Results:

• Metabolic derangements are evident in IPF, affecting cellular functions and disease progression.
• Current IPF models show variability in metabolic profiling compared to patient data.
• Metabolism represents a critical, yet largely untapped, therapeutic target for IPF.

Conclusions:

• Understanding cell-specific metabolic alterations is key to unraveling IPF pathogenesis.
• Improved in vitro modeling is needed for developing disease-modifying therapeutics.
• Targeting dysregulated metabolism holds potential for novel IPF treatments.